Sarah Calve

Sarah Calve

Auto-generated profile, based on publicly available information

Sarah Calve

Paul M. Rady Department of Mechanical Engineering, Materials Science and Engineering Program, Biomedical Engineering Program, University of Colorado Boulder, Boulder, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2020 in Nature Methods
Verified
Journal Article
Closed access
PDF file
FXFan Xu
Fan Xu
DMDonghan Ma
Donghan Ma
KMKathryn P. MacPherson
Kathryn P. MacPherson
SLSheng Liu
Sheng Liu
YBYe Bu
Ye Bu
FHFang Huang
Fang Huang

2 December 2021 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
BSBenjamin Seelbinder
Benjamin Seelbinder
SGSoham Ghosh
Soham Ghosh
SSStephanie E. Schneider
Stephanie E. Schneider
ASAdrienne K. Scott
Adrienne K. Scott
ABAlycia G. Berman
Alycia G. Berman
CNCorey Neu
Corey Neu

1 January 2019 in Acta Biomaterialia
Verified
Journal Article
Closed access
JGJuan Martin Silva Garcia
Juan Martin Silva Garcia
APAlyssa Panitch
Alyssa Panitch
SCSarah Calve
Sarah Calve

30 August 2016 in Scientific Reports
Verified
Journal Article
Open access
SCSarah Calve
Sarah Calve
AWAndrew J. Witten
Andrew J. Witten
AOAlexander R. Ocken
Alexander R. Ocken
TKTamara Kinzer-Ursem
Tamara Kinzer-Ursem
Analysis of the developing proteome has been complicated by a lack of tools that can be easily employed to label and identify newly synthesized proteins within complex biological mixtures. Here, we demonstrate that the methionine analogs azidohomoalanine and homopropargylglycine can be globally incorporated into the proteome of mice through facile intraperitoneal injections. These analogs contain bio-orthogonal chemical handles to which fluorescent tags can be conjugated to identify newly synthesized proteins. We show these non-canonical amino acids are incorporated into various tissues in juvenile mice and in a concentration dependent manner. Furthermore, administration of these methionine analogs to pregnant dams during a critical stage of murine development, E10.5–12.5 when many tissues are assembling, does not overtly disrupt development as assessed by proteomic analysis and normal parturition and growth of pups. This successful demonstration that non-canonical amino acids can be directly administered in vivo will enable future studies that seek to characterize the murine proteome during growth, disease and repair.

1 May 2019 in Matrix Biology
Verified
Journal Article
Closed access
YLYue Leng
Yue Leng
AAAmmara Abdullah
Ammara Abdullah
MWMichael Wendt
Michael Wendt
SCSarah Calve
Sarah Calve

17 May 2020 in Cancers
Verified
Journal Article
Open access
PDF file
SLSarah Libring
Sarah Libring
ASAparna Shinde
Aparna Shinde
MCMonica K. Chanda
Monica K. Chanda
MNMaryam Nuru
Maryam Nuru
HGHeather George
Heather George
Luis SolorioLuis Solorio
Luis Solorio
In breast cancer (BC), tissue stiffening via fibronectin (FN) and collagen accumulation is associated with advanced disease progression at both the primary tumor and metastatic sites. Here, we evaluate FN production in 15 BC cell lines, representing a variety of subtypes, phenotypes, metastatic potentials, and chemotherapeutic sensitivities. We demonstrate that intracellular and soluble FN is initially lost during tumorigenic transformation but is rescued in all lines with epithelial-mesenchymal plasticity (EMP). Importantly, we establish that no BC cell line was able to independently organize a robust FN matrix. Non-transformed mammary epithelial cells were also unable to deposit FN matrices unless transglutaminase 2, a FN crosslinking enzyme, was overexpressed. Instead, BC cells manipulated the FN matrix production of fibroblasts in a phenotypic-dependent manner. In addition, varied accumulation levels were seen depending if the fibroblasts were conditioned to model paracrine signaling or endocrine signaling of the metastatic niche. In the former, fibroblasts conditioned by BC cultures with high EMP resulted in the largest FN matrix accumulation. In contrast, mesenchymal BC cells produced extracellular vesicles (EV) that resulted in the highest levels of matrix formation by conditioned fibroblasts. Overall, we demonstrate a dynamic relationship between tumor and stromal cells within the tumor microenvironment, in which the levels and fibrillarization of FN in the extracellular matrix are modulated during the particular stages of disease progression.